Alemtuzumab reduces ms disease activity in active relapsing‐remitting multiple sclerosis patients who had disease activity on prior therapy

Authors
Category Primary study
JournalNeurology
Year 2013
This article has no abstract
Epistemonikos ID: dc5748af27f6534897270ad2cce6395d38f684e0
First added on: Aug 10, 2018